COMPASS Pathways

IPO

We connect science and compassion to reimagine mental health care.

London, United Kingdom · Founded 2016 · $972.0M raised

Headquarters
London
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$972.0M
Last Round
$200.0M Venture RoundFeb 2026
Rounds
9

About

COMPASS Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is developing COMP360 psilocybin therapy, currently in Phase 3 clinical trials for treatment-resistant depression, as well as studies for PTSD and anorexia nervosa. Listed on Nasdaq as CMPS, COMPASS holds FDA Breakthrough Therapy designation for its lead candidate.

Summary

COMPASS Pathways is a Healthcare company based in London, United Kingdom, founded in 2016. It has raised $972.0M in total across 9 rounds, most recently a $200.0M Venture Round round in Feb 2026. Investors include Peter Thiel, ATAI Life Sciences and Christian Angermayer.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundFeb 2026
$200.0M

Sign up to see all 10 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

COMPASS Pathways on Indexed.vc
<a href="https://indexed.vc/companies/compass-pathways"><img src="https://indexed.vc/api/badge/company/compass-pathways" alt="COMPASS Pathways on Indexed.vc" width="260" height="76" /></a>